NIAB
  Skip Navigation Links  
  Digital India
 

Dr. Anand Srivastava, Scientist C Name:

Designation:

Areas of Specialization:

E-mail:
Anand Srivastava

Scientist-C

Molecular Parasitology, Entomology, Host-pathogen interaction(s), Molecular interactions

anand[at]niab[dot]org[dot]in
     

Laboratory of Molecular Interactions

Education and training:

Dr. Anand Srivastava completed B.Sc. (1999) from University of Delhi, Delhi, and M.Sc. (2001; Biotechnology) from the Allahabad University, Allahabad, India. He did Ph.D. (2008) from Jawaharlal University (JNU) working at International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi, India. He then worked at Institut Pasteur, Paris (2008-2011) and Institut National de Transfusion Sanguine, Paris (2011-2012) as a Post-doctoral Fellow. He joined National Institute of Animal Biotechnology (NIAB) in 2013.


Research experience and interests:

Dr. Srivastava has vast experience in parasite biology. He has worked intensively on malaria parasite where his research focus was understanding molecular host-parasite interaction(s). Presently he is working on a veterinary important parasite Theileria. His research interests are to understand the molecular basis of the disease Theileriosis. He is also interested in understanding the biology of the vector (tick) which transmits the Theileria parasite.


Selected awards, honours and fellowships:
  1. Best Oral presentation award, 13th Conference on Vectors and Vector Borne Diseases, Chennai, 2017.

  2. Postdoctoral Fellowship, Fondation pour la Recherche Médicale (FRM), France (2011-2012).

  3. Keystone Symposia Scholarship, 2010.

  4. Fellowship to attend PHARE workshop, Martina Franca, Italy, 2009.
Selected publications:
  1. de Moraes LV, Dechavanne S, Sousa PM, Barateiro A, Cunha SF, Nunes-Silva S, Lima FA, Murillo O, Marinho CR, Gangnard S, Srivastava A, Braks JA, Janse CJ, Gamain B, Franke-Fayard B, Penha-Gonçalves C. 2016. A murine model for pre-clinical studies on Var2CSA-mediated pathology associated to malaria in pregnancy. Infection and Immunity 84(6):1761-4.

  2. Gangnard S, Lewit-Bentley A, Dechavanne S, Srivastava A, Amirat F, Bentley GA, Gamain B. 2015. Structure of the DBL3X-DBL4ε region of the VAR2CSA placental malaria vaccine candidate: insight into DBL domain interactions. Scientific Reports 5:14868.

  3. Dechavanne S, Srivastava A, Gangnard S, Nunes-silva S, Dechavanne C, Fievet N, Deloron P, Chêne A, Gamain B. 2015. The parity-dependent recognition of the DBL1X-3X suggests an important role of the VAR2CSA high affinity CSA-binding region in the development of the humoral response against placental malaria. Infection and Immunity 83(6):2466-74.

  4. Gullingsrud J, Milman N, Saveria T, Chesnokov O, Williamson K, Srivastava A, Gamain B, Duffy PE, Oleinikov AV. 2015. High-throughput screening platform identifies small molecules that prevent sequestration of Plasmodium falciparum-infected erythrocytes. Journal of Infectious Diseases 211(7):1134-43.

  5. Srivastava A, Gangnard S, Dechavanne S, Amirat F, BentleyGA, Bentley GA and Gamain B. 2011. Var2CSA minimal CSA binding region is located within the N-terminal region. PLoS ONE 6(5):e20270.

  6. Rathore S, Jain S, Sinha D, Gupta M, Asad M, Srivastava A, Narayanan MS, Ramasamy G, Chauhan VS, Gupta D, and Mohmmed A. 2011. Disruption of a mitochondrial protease machinery in Plasmodium falciparum is an intrinsic signal for parasite cell death. Cell Death and Disease 2:e231.

  7. Avril M, Hathaway MJ, Srivastava A, Dechavanne S, Hommel M, Beeson JG, Smith JD, Gamain B. 2011. Antibodies to a full-length VAR2CSA immunogen are broadly strain-transcendent but do not cross-inhibit different placental-type parasite isolates. PLoS ONE 6(2):e16622.

  8. Srivastava A, Singh S, Dhawan S, Alam MM, Mohmmed A, Chitnis CE. 2010. Localization of apical Sushi protein in Plasmodium falciparum merozoites. Molecular and Biochemical Parasitology 174(1):66-9.

  9. Srivastava A, Gangnard S, Round A, Dechavanne S, Juillerat A, Raynal B, Faure G, Baron B, Ramboarina S, Singh SK, Belrhali H, England P, Lewit-Bentley A, Scherf A, Bentley GA, Gamain B. 2010. Full-length extracellular region of the var2CSA variant of PfEMP1 is required for specific, high-affinity binding to CSA. Proceedings of the National Academy of Sciences of USA 107(11):4884-9.

  10. Mayor A, Rovira-Vallbona E, Srivastava A, Sharma SK, Pati SS, Puyol L, Quinto L, Bassat Q, Machevo S, Mandomando I, Chauhan VS, Alonso PL, Chitnis CE. 2009. Functional and immunological characterization of a Duffy Binding-Like alph1 a domain from Plasmodium falciparum-erythrocyte membrane protein-1 that mediates resetting. Infection and Immunity 77(9):3857-63.

Detailed profile





 
Mission & Vision

Mission: Development of sustainable and  globally competitive livestock industry through innovative technology.

Vision: To demonstrate excellence in promoting and commercializing leads in biotechnology and to produce globally competitive livestock products, pharmaceuticals and biologicals for animal health care.

Important Links


Advertisement No. 9/2017New

Advertisement No. 10/2017New

Advertisement No. 8/2017New

GST DetailsNew

TendersNew

Advertisement No. 7/2017

Forthcoming NIAB

Opportunities for Indian Scientists Working Abroad

Integrity Pledge

Digital NIAB

SPMS

Digital India Week

Annual Reports
 
  [ Log In ]  | RTI | DisclaimerContact | Copyrights © NIAB | Last updated date: 20-Aug-2017